Dr. Succi said that the artificial intelligence-based tool could produce a correct diagnosis close to the level of a third- or fourth-year medical student. However, he warned that the tool could also fabricate sources.
“I would express considerable caution using this in a clinical scenario for any reason, at the current stage,” Dr. Succi said.
The news comes after a Baltimore-based University of Maryland Medicine study found that ChatGPT provided correct information about breast cancer screening 88 percent of the time.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
